FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2905067512> ?p ?o ?g. }

• W2905067512 endingPage "e0208824" @default.
• W2905067512 startingPage "e0208824" @default.
• W2905067512 abstract "To quantify changes in anticoagulant use in Australia since the introduction of Non-vitamin K antagonist anticoagulants (NOACs) and to estimate government expenditure.Interrupted-time-series analysis quantifying anticoagulant dispensing, before and after first Pharmaceutical Benefits Scheme (PBS) NOAC listing in August 2009 for venous thromboembolism prevention; and expanded listing for stroke prevention in non-valvular atrial fibrillation (AF) in August 2013, up to June 2016. Estimated government expenditure on PBS-listed anticoagulants.PBS dispensing in 10% random sample of Australians, restricted to continuous concessional beneficiaries dispensed oral anticoagulants from July 2005 to June 2016. Total PBS anticoagulant expenditure was calculated using Medicare Australia statistics.Monthly dispensing and initiation of oral anticoagulants (warfarin, rivaroxaban, dabigatran or apixaban). Annual PBS anticoagulant expenditure.An estimated 149,180 concessional beneficiaries were dispensed anticoagulants (100% warfarin) during July 2005. This increased to 292,550 during June 2016, of whom 47.0%, 27.1%, 18.7% and 7.2% were dispensed warfarin, rivaroxaban, apixaban and dabigatran, respectively. Of 16,500 initiated on anticoagulants in June 2016, 24.3%, 38.2%, 30.0% and 7.5% were initiated on warfarin, rivaroxaban, apixaban, and dabigatran, respectively. Compared to July 2005-July 2013, from August 2013-June 2016, dispensings for all anticoagulants increased by 2,303 dispensings/month (p<0.001, 95%CI = [1,229 3,376]); warfarin dispensing decreased by 1,803 dispensings/month (p<0.001, 95%CI = [-2,606, -1,000]). Total PBS anticoagulant expenditure was $19.5 million (97.0% concessional) in 2008/09, of which 100% was warfarin and $203.3 million (86.2% concessional) in 2015/16, of which 11.2% was warfarin.The introduction of the NOACs led to substantial increases in anticoagulant use and expenditure in Australia." @default.
• W2905067512 created "2018-12-22" @default.
• W2905067512 creator A5004641212 @default.
• W2905067512 creator A5005800013 @default.
• W2905067512 creator A5016316637 @default.
• W2905067512 creator A5037560809 @default.
• W2905067512 creator A5038232677 @default.
• W2905067512 creator A5075704884 @default.
• W2905067512 creator A5090894020 @default.
• W2905067512 date "2018-12-06" @default.
• W2905067512 modified "2023-10-01" @default.
• W2905067512 title "Rapid and substantial increases in anticoagulant use and expenditure in Australia following the introduction of new types of oral anticoagulants" @default.
• W2905067512 cites W1522694313 @default.
• W2905067512 cites W1757837840 @default.
• W2905067512 cites W1898025493 @default.
• W2905067512 cites W1980300036 @default.
• W2905067512 cites W1983506435 @default.
• W2905067512 cites W1999468381 @default.
• W2905067512 cites W2004504033 @default.
• W2905067512 cites W2014924181 @default.
• W2905067512 cites W2015854890 @default.
• W2905067512 cites W2027889408 @default.
• W2905067512 cites W2034191886 @default.
• W2905067512 cites W2036605610 @default.
• W2905067512 cites W2042345206 @default.
• W2905067512 cites W2054623522 @default.
• W2905067512 cites W2106828417 @default.
• W2905067512 cites W2126789285 @default.
• W2905067512 cites W2128415369 @default.
• W2905067512 cites W2156687558 @default.
• W2905067512 cites W2163345245 @default.
• W2905067512 cites W2474726212 @default.
• W2905067512 cites W2753051611 @default.
• W2905067512 cites W4206535002 @default.
• W2905067512 doi "https://doi.org/10.1371/journal.pone.0208824" @default.
• W2905067512 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6283555" @default.
• W2905067512 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30521639" @default.
• W2905067512 hasPublicationYear "2018" @default.
• W2905067512 type Work @default.
• W2905067512 sameAs 2905067512 @default.
• W2905067512 citedByCount "26" @default.
• W2905067512 countsByYear W29050675122019 @default.
• W2905067512 countsByYear W29050675122020 @default.
• W2905067512 countsByYear W29050675122021 @default.
• W2905067512 countsByYear W29050675122022 @default.
• W2905067512 countsByYear W29050675122023 @default.
• W2905067512 crossrefType "journal-article" @default.
• W2905067512 hasAuthorship W2905067512A5004641212 @default.
• W2905067512 hasAuthorship W2905067512A5005800013 @default.
• W2905067512 hasAuthorship W2905067512A5016316637 @default.
• W2905067512 hasAuthorship W2905067512A5037560809 @default.
• W2905067512 hasAuthorship W2905067512A5038232677 @default.
• W2905067512 hasAuthorship W2905067512A5075704884 @default.
• W2905067512 hasAuthorship W2905067512A5090894020 @default.
• W2905067512 hasBestOaLocation W29050675121 @default.
• W2905067512 hasConcept C126322002 @default.
• W2905067512 hasConcept C2426938 @default.
• W2905067512 hasConcept C2776301958 @default.
• W2905067512 hasConcept C2776704044 @default.
• W2905067512 hasConcept C2778205648 @default.
• W2905067512 hasConcept C2778661090 @default.
• W2905067512 hasConcept C2778793514 @default.
• W2905067512 hasConcept C2778810321 @default.
• W2905067512 hasConcept C2779161974 @default.
• W2905067512 hasConcept C2780638905 @default.
• W2905067512 hasConcept C42219234 @default.
• W2905067512 hasConcept C71924100 @default.
• W2905067512 hasConcept C98274493 @default.
• W2905067512 hasConceptScore W2905067512C126322002 @default.
• W2905067512 hasConceptScore W2905067512C2426938 @default.
• W2905067512 hasConceptScore W2905067512C2776301958 @default.
• W2905067512 hasConceptScore W2905067512C2776704044 @default.
• W2905067512 hasConceptScore W2905067512C2778205648 @default.
• W2905067512 hasConceptScore W2905067512C2778661090 @default.
• W2905067512 hasConceptScore W2905067512C2778793514 @default.
• W2905067512 hasConceptScore W2905067512C2778810321 @default.
• W2905067512 hasConceptScore W2905067512C2779161974 @default.
• W2905067512 hasConceptScore W2905067512C2780638905 @default.
• W2905067512 hasConceptScore W2905067512C42219234 @default.
• W2905067512 hasConceptScore W2905067512C71924100 @default.
• W2905067512 hasConceptScore W2905067512C98274493 @default.
• W2905067512 hasIssue "12" @default.
• W2905067512 hasLocation W29050675121 @default.
• W2905067512 hasLocation W29050675122 @default.
• W2905067512 hasLocation W29050675123 @default.
• W2905067512 hasLocation W29050675124 @default.
• W2905067512 hasLocation W29050675125 @default.
• W2905067512 hasLocation W29050675126 @default.
• W2905067512 hasLocation W29050675127 @default.
• W2905067512 hasOpenAccess W2905067512 @default.
• W2905067512 hasPrimaryLocation W29050675121 @default.
• W2905067512 hasRelatedWork W2060633440 @default.
• W2905067512 hasRelatedWork W2181601210 @default.
• W2905067512 hasRelatedWork W2292941107 @default.
• W2905067512 hasRelatedWork W2509901103 @default.
• W2905067512 hasRelatedWork W2793392713 @default.
• W2905067512 hasRelatedWork W2905067512 @default.
• W2905067512 hasRelatedWork W3173880122 @default.

• next